iLite® ADCC Target mTNF-alpha (+) Assay Ready Cells

Add to my product list

iLite® ADCC Target mTNF-alpha (+) Assay Ready Cells are based on a human embryonic kidney cell line, HEK293 (ATCC# CRL-1573), and have been genetically engineered and optimized to express high and constant levels of the surface antigen mTNF-alpha. The cells are to be use as target cells together with iLite ADCC Effector (V) Assay Ready Cells for measuring the ADCC activity of anti-TNF-alpha antibodies.

Product code
Detection system
Research Use Only (RUO)

The iLite® ADCC Target mTNF-alpha (+) Assay Ready Cells can be used together with iLite® ADCC Effector (V) and iLite® ADCC Target mTNF-alpha (-) Assay Ready Cells for the quantification ADCC activity. Please see:

  • Quantification of anti-mTNF-alpha ADCC activity (LABELDOC0402)

Antibody-dependent cell-mediated cytotoxicity (ADCC) is a mechanism whereby pathogenic cells are lysed by lymphocytes, most often Natural Killer (NK) cells. The mechanism involves binding of antibodies to surface antigens on the pathogen. Crosslinking of these antibodies to NK cells through the binding of the Fc-portion to Fc receptors on the NK cells leads to activation of the NK cell and formation of an immune synapse with the pathogenic cell. The NK cell releases cytotoxic granules containing granzymes and perforin into the synapse, leading to apoptosis of the targeted cell (1). 

>250 µL of iLite® Assay Ready Cells suspended in cryoprotective medium from Gibco (cat no 12648-010).